Article
Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of…
Patient Preference and Adherence · 2020 · Cagnacci A, Xholli A, Venier M
Key facts
| Title | Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use |
|---|---|
| First author | Cagnacci A, Xholli A, Venier M |
| Journal | Patient Preference and Adherence |
| Published | Jan 10, 2020 |
| DOI | 10.2147/PPA.S203614 |
| Devices mentioned | 203614, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 2 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1